Application of rhizoma sparganii extract in preparation of external preparation for skin after-sun repair

By using triangular extract to inhibit oxidative stress, inflammatory response and pigmentation, the problem of poor skin repair effect in the prior art is solved, and multiple signal pathways are protected after sunlight are achieved, which significantly reduces after sunlight. Symptoms of injury.

CN118986830AActive Publication Date: 2024-11-22ZHAOLAI HLDG (SUZHOU) CO LTD +1

Patent Information

Application Number
CN202411269889.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-11
Publication Date
2024-11-22
Estimated Expiration
2044-09-11

AI Technical Summary

Technical Problem

The existing repair preparations for skin post-sun damage on the market are limited in effect, and the research on mechanism targets is not transparent enough to solve the problem of skin post-sun damage in all aspects.

Method used

Triangular extract is used as the main component to protect the skin from damage caused by ultraviolet radiation by inhibiting oxidative stress, inflammatory response and pigmentation, and protecting the skin from damage caused by ultraviolet radiation.

Benefits of technology

Triangular extract can eliminate free radicals, inhibit lipid peroxidation, downregulate AGEs expression, reduce NF-κB and HMGB1 gene expression, inhibit the secretion of inflammatory factor TNF-α, and reduce the expression of the melanotic factor α-MSH and β-catenin. Significantly alleviates the symptoms of skin damage after sunlight and provides a comprehensive skin repair effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention belongs to the technical field of cosmetics, and particularly relates to application of a rhizoma sparganii extract in preparation of an external preparation for skin after-sun repair. The rhizoma sparganii extract prepared by the invention can scavenge free radicals, inhibit lipid peroxidation, inhibit the production of ROS and down-regulate the expression of AGEs, and also can inhibit inflammatory reactions induced by ultraviolet rays, reduce the expression of NF-kappa B and HMGB1 genes up-regulated by the ultraviolet rays, inhibit the secretion of inflammatory factors TNF-alpha, inhibit the growth of tumors, inhibit the growth of tumors, inhibit the growth of tumors and inhibit the growth of tumors. Meanwhile, expression of alpha-MSH and beta-catenin genes which are up-regulated by ultraviolet rays can be reduced, generation of melanin and transport of melanosomes can be inhibited, and in other words, the symptoms of skin after-sun injury can be remarkably relieved by improving multiple signal channels such as skin oxidative injury, inflammatory response and hyperpigmentation caused by the ultraviolet rays; when being applied to external preparations such as cosmetics for repairing after-sun skin injury, the composition has a wide market application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of cosmetics, and particularly relates to application of a Tripterygium wilfordii extract in preparing an external preparation for repairing skin after sun exposure. Background Art

[0002] As an important organ in direct contact with the external environment, the skin is exposed to solar radiation for a long time and is susceptible to damage from ultraviolet radiation (UVR). According to the degree and duration of damage, it is mainly divided into chronic damage and acute damage. Chronic damage, also known as photoaging, has clinical manifestations such as dryness, yellowing, sagging, capillary dilation, a large number of deep wrinkles in addition to fine lines, irregular pigmentation, etc.; according to the degree of damage, acute post-sun damage can be divided into mild pigmentation and severe sunburn. According to different mechanisms of occurrence, skin pigmentation can be divided into immediate tanning reaction (IPD), persistent tanning reaction (PPD) and delayed tanning reaction (DT). Sunburn is mainly caused by excessive exposure of the skin to UVB irradiation. Its clinical manifestations are mainly erythema, stratum corneum desquamation and edema, etc., accompanied by pain.

[0003] Further research has shown that acute and chronic sun damage have the same causes, as follows:

[0004] (1) Light can activate chromophores in the skin to react with molecular oxygen, leading to the generation of reactive oxygen species (ROS). When the amount of reactive oxygen species generated exceeds the body's ability to remove them, oxidative stress occurs in the skin. Oxidative stress can cause damage to lipids, proteins, and DNA, and can even accelerate the formation of advanced glycation end products (AGEs) and further promote inflammatory responses.

[0005] (2) Light damages the living cell layer and the skin barrier. The damaged cell membrane releases pro-inflammatory factors, which further activate inflammation-related signaling pathways such as NF-κB, mediating the occurrence and strengthening of inflammatory responses, expressing more inflammatory factors, and producing inflammatory infiltration. When the skin is damaged by the sun, the skin barrier's ability to resist ultraviolet rays decreases, the immune response is suppressed, and HMGB1 is released from damaged or dead cells. It participates in the inflammatory response as a signal molecule, regulates the immune response, and further strengthens the inflammatory response. Subsequently, symptoms of skin damage after the sun, such as skin sun erythema, chronic inflammatory photoaging, skin sun darkening, and photosensitivity, appear on the surface of the skin.

[0006] (3) Light exposure will cause the melanin already present in the cells to be oxidized by reactive oxygen species and other radicals produced by UVA, thereby turning into darker oxidized melanin and accelerating the transport of melanosomes in melanocytes. At the same time, after UVB irradiation stimulates the skin, it further promotes the expression of MITF by secreting related induction factors such as the MC1R / α-MSH signaling pathway and the Wnt / β-catenin signaling pathway, activating tyrosinase in melanocytes, and ultimately increasing the number and activity of melanocytes and promoting the synthesis of melanin; promoting the growth of melanocyte dendrites and stimulating the transfer of mature melanosomes along the dendrites of melanocytes to keratinocytes, thereby causing a tanning reaction in the skin.

[0007] There are few functional preparations on the market for repairing skin after sun exposure, the research on mechanism targets is not transparent enough, and the single mechanism of action has limited effect, which is not enough to solve the problem of skin damage after sun exposure in an all-round way. It requires the superposition of multiple ingredients to achieve a certain effect. Summary of the invention

[0008] The purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art and provide an application of the Tripterygium wilfordii extract in the preparation of an external preparation for skin after-sun repair.

[0009] In a first aspect, the present invention provides the use of a Tripterygium wilfordii extract in the preparation of an external preparation for repairing skin after sun exposure.

[0010] Preferably, the extract of Tripterygium wilfordii exerts the effect of repairing skin after sun exposure through at least one of the following aspects:

[0011] a. Inhibit oxidative stress caused by sun damage to skin tissue;

[0012] b. Inhibit the inflammatory response caused by sun damage to skin tissue;

[0013] c. Inhibit pigmentation caused by sun damage to skin tissue.

[0014] The dried tuber of the black sparge plant of the black sparge family is peeled off. It is bitter in taste and flat in nature. It enters the liver and spleen meridians. It was originally recorded in "Compendium of Materia Medica" and has the effects of breaking blood and promoting qi, eliminating accumulation and relieving pain. It is used for lumps and masses, amenorrhea due to blood stasis, distending pain due to food accumulation, etc. It is a commonly used blood circulation and stasis-removing medicine in clinical practice. In the prior art, the research on the application of the extract of the sparge in cosmetics is that it is often compounded with other components for preventing or treating skin problems related to acne due to its good antibacterial effect. There is no report on the use of the extract of the sparge to improve skin damage after sun exposure. Therefore, the efficacy research of the extract of the sparge to improve skin damage after sun exposure has novelty and great market potential.

[0015] The present invention has found through experimental research that the extract of Tripterygium wilfordii can reduce multiple signal pathways such as oxidative stress, inflammatory response, pigmentation, etc. to protect the skin from sun damage caused by ultraviolet radiation. Among them, the extract of Tripterygium wilfordii can improve cell oxidative damage by scavenging free radicals, inhibiting lipid peroxidation, inhibiting the production of ROS, and down-regulating the expression of AGEs; the extract of Tripterygium wilfordii can also inhibit the secretion of inflammatory factor TNF-α by reducing the expression of NF-κB and HMGB1 genes upregulated by ultraviolet rays, thereby inhibiting the inflammatory response induced by ultraviolet rays; in addition, the extract of Tripterygium wilfordii can also reduce the expression of melanin-promoting factor α-MSH and synthesis and transport-related gene β-catenin upregulated by ultraviolet rays, inhibit the production of melanin and the transport of melanosomes, thereby improving pigmentation caused by ultraviolet rays.

[0016] In a second aspect, the present invention provides a method for preparing the above-mentioned Tripterygium wilfordii extract, comprising the following steps:

[0017] (1) crushing the three-sided tuber, passing it through a 40-60 mesh sieve, soaking it in an ethanol solution, and then refluxing and extracting it for 1.5-2.5 hours, filtering it to obtain a first extract, and then refluxing and extracting the filter residue with an ethanol solution for 1.5-2.5 hours, filtering it, and obtaining a second extract;

[0018] (2) Reflux extraction of the filter residue with an ethanol solution for 0.5-1.5 h to obtain a third extract, combine the three extracts, remove the ethanol under reduced pressure, filter and collect the filtrate to obtain the Trillium extract.

[0019] Preferably, the temperatures of the three reflux extractions are all 75-85°C.

[0020] Preferably, the volume concentration of the ethanol solution is 60-70%.

[0021] The present invention adopts the preparation method to extract the Trillium extract, and the preparation process is simple. It is found through experimental research that the particle size of the Trillium particles, the reflux extraction temperature, the ethanol concentration used for extraction and the number of extractions during extraction will have an important influence on the content of flavonoids and polyphenols in the Trillium extract finally obtained. Within the above-mentioned specified process conditions, the flavonoids and polyphenols in the Trillium extract can be fully dissolved and their degradation or destruction can be avoided, thereby maximizing the extraction efficiency of the active ingredients, thereby achieving a better sun damage repair effect.

[0022] In a third aspect, the present invention provides a cosmetic for repairing skin after sun exposure, the cosmetic comprising the Trillium gracile extract obtained by the above preparation method, the mass percentage of the Trillium gracile extract in the cosmetic is 1-60%.

[0023] Preferably, the cosmetics also include common cosmetic excipients, including polyols, preservatives and solubilizers; the polyols include at least one of propylene glycol, pentylene glycol and dipropylene glycol; the preservatives include at least one of p-hydroxyacetophenone, chlorphenesin and phenoxyethanol; the solubilizers include at least one of PEG caprylic / capric glycerides and hydrogenated lecithin.

[0024] Preferably, the cosmetic dosage form includes at least one of an aqueous solution, an emulsion, and a cream.

[0025] In a fourth aspect, the present invention provides an emulsion for repairing skin after sun exposure, the emulsion comprising the Trillium gracile extract obtained by the above-mentioned preparation method; the mass percentage of the Trillium gracile extract in the emulsion is 1-3%.

[0026] Preferably, the emulsion further comprises 10-15% of moisturizer, 5-10% of emulsifier, 0.2-0.7% of antioxidant, 1-3% of thickener, 1-2% of preservative and the balance of water.

[0027] Preferably, the moisturizing agent comprises at least one of glycerin, sodium hyaluronate, propylene glycol, squalane, caprylic / capric glyceride, glucose, butylene glycol, 1,2-pentanediol, caprylyl glycol and isopentyl glycol;

[0028] The emulsifier includes at least one of acrylic acid (ester) / acrylamide copolymer, isopropyl myristate, LC14-22 alcohol, C12-20 alkyl glucoside, stearic acid, cetearyl olivate, sorbitan olivate, Span 80, glyceryl stearate, PEG-100 stearate, steareth-2, steareth-21, ceteareth-12, ceteareth-30, potassium cetyl phosphate, sodium stearoyl glutamate, polysorbate-60 and sorbitan stearate;

[0029] The antioxidant comprises at least one of sodium pyrosulfite, tocopherol and tocopherol acetate;

[0030] The thickener comprises at least one of polyacrylate crosspolymer-6, xanthan gum, cetearyl alcohol, carbomer and hydroxyethyl cellulose;

[0031] The preservative comprises at least one of p-hydroxyacetophenone, 1,2-hexanediol, chlorphenesin, caprylhydroxamic acid, benzyl alcohol, phenoxyethanol, benzoic acid and its salts, and sorbic acid and its salts.

[0032] Compared with the prior art, the present invention has the following beneficial effects:

[0033] The extract of Tripterygium wilfordii prepared by the invention can scavenge free radicals, inhibit lipid peroxidation, inhibit the generation of ROS, down-regulate the expression of AGEs, inhibit the inflammatory response induced by ultraviolet rays, reduce the expression of NF-κB and HMGB1 genes up-regulated by ultraviolet rays, inhibit the secretion of inflammatory factor TNF-α, and simultaneously reduce the expression of melanin-promoting factor α-MSH and β-catenin genes up-regulated by ultraviolet rays, inhibit the generation of melanin and the transport of melanosomes, that is, significantly reduce the symptoms of skin damage caused by sun exposure by improving multiple signal pathways such as skin oxidative damage, inflammatory response, pigmentation, etc. caused by ultraviolet rays, and will have broad market application prospects when applied to external preparations such as cosmetics for repairing skin damage caused by sun exposure. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 Figure 1 is a diagram of ROS scavenging effect, wherein Figure a is the ROS scavenging condition of the blank control group, Figure b is the ROS scavenging condition of the positive control group (glutathione), and Figure c is the ROS scavenging condition of 0.5% Tripterygium wilfordii extract;

[0035] Figure 2 The fluorescence microscope observation images of melanosomes after treatment with different test samples;

[0036] Figure 3 is the relative average value of melanosomes after treatment with different test samples (x±s), * indicates that the difference compared with M is statistically significant **P<0.01;

[0037] Figure 4 The comparison diagram of the spots on the subjects before (a) using the emulsion containing the Tripterygium wilfordii extract and after 56 days of use (b);

[0038] Figure 5 The comparison diagram of ultraviolet spots on the subjects before (a) using the emulsion containing the Tripterygium wilfordii extract and after 56 days of use (b);

[0039] Figure 6 Comparison of brown spots on the subjects before (a) using the emulsion containing the Tripterygium wilfordii extract and after 56 days of use (b);

[0040] Figure 7 The figures are comparisons of the red areas before (a) and 56 days after (b) using the emulsion containing the Tripterygium wilfordii extract. DETAILED DESCRIPTION

[0041] To better illustrate the content of the present invention, the present invention will be further described below in conjunction with the accompanying drawings and specific embodiments.

[0042] Unless otherwise specified, the raw materials or reagents used in the present invention are all conventional reagents in the art and can be purchased through commercial channels. Experimental operations not specifically described in the present invention are all conventional operations in the art or can be understood or known by those skilled in the art based on the existing technology or common knowledge they master.

[0043] Example 1

[0044] This embodiment provides a method for preparing a Tripterygium wilfordii extract, comprising the following steps:

[0045] The dried tubers of Sparganium stoloniferum Buch.-Ham. from the Sparganium family are selected, crushed, and passed through a 50-mesh sieve, 1 kg of Sparganium powder is weighed, 5 times the amount of 70% ethanol is added, soaked overnight, refluxed at 80°C for extraction for 2 hours, and filtered; 5 times the amount of 70% ethanol is added to the filter residue, refluxed at 80°C for extraction for 2 hours, and then filtered; 3 times the amount of 70% ethanol is added to the filter residue, refluxed at 80°C for extraction for 1 hour, the three filtrates are combined, ethanol is recovered under reduced pressure, and the mixture is allowed to stand and filtered to obtain the Sparganium extract.

[0046] Example 2

[0047] This embodiment provides a method for preparing a Tripterygium wilfordii extract, comprising the following steps:

[0048] The dried tubers of Tripterygium wilfordii from the Tripterygium wilfordii plant of the Tripterygium wilfordii family are selected, crushed, and passed through a 40-mesh sieve. 1 kg of Tripterygium wilfordii powder is weighed, 5 times the amount of 60% ethanol is added, soaked overnight, refluxed at 75°C for extraction for 1.5 hours, and filtered; 5 times the amount of 60% ethanol is added to the filter residue, refluxed at 85°C for extraction for 2 hours, and then filtered; 3 times the amount of 70% ethanol is added to the filter residue, refluxed at 80°C for extraction for 0.5 hours, the three filtrates are combined, the ethanol is recovered under reduced pressure, and the mixture is allowed to stand and filtered to obtain the Tripterygium wilfordii extract.

[0049] Example 3

[0050] This embodiment provides a method for preparing a Tripterygium wilfordii extract, comprising the following steps:

[0051] The dried tubers of Tripterygium wilfordii from the Tripterygium wilfordii family are selected, crushed, and passed through a 60-mesh sieve. 1 kg of Tripterygium wilfordii powder is weighed, 5 times the amount of 70% ethanol is added, soaked overnight, refluxed at 85°C for extraction for 2.5 hours, and filtered; 5 times the amount of 70% ethanol is added to the filter residue, refluxed at 75°C for extraction for 2 hours, and then filtered; 3 times the amount of 60% ethanol is added to the filter residue, refluxed at 80°C for extraction for 1.5 hours, the three filtrates are combined, the ethanol is recovered under reduced pressure, and the mixture is allowed to stand and filtered to obtain the Tripterygium wilfordii extract.

[0052] Comparative Example 1

[0053] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that the Tripterygium wilfordii tubers are crushed and passed through a 20-mesh sieve, and the other conditions are the same.

[0054] Comparative Example 2

[0055] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that the Tripterygium wilfordii tubers are crushed and then passed through an 80-mesh sieve, and the other conditions are the same.

[0056] Comparative Example 3

[0057] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that a conventional ultrasonic extraction method is used to replace ethanol reflux extraction, and the conditions for the ultrasonic extraction are: ultrasonic extraction at a power of 300 W for 2 h and a temperature of 80°C.

[0058] Comparative Example 4

[0059] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that the volume concentration of the ethanol solution is 50%, and the other conditions are the same.

[0060] Comparative Example 5

[0061] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that the volume concentration of the ethanol solution is 80%, and the other conditions are the same.

[0062] Comparative Example 6

[0063] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that the temperature during reflux extraction is 65° C., and other conditions are the same.

[0064] Comparative Example 7

[0065] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that the temperature during reflux extraction is 95° C., and other conditions are the same.

[0066] Comparative Example 8

[0067] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that the third reflux extraction time is 2 h, and the other conditions are the same.

[0068] Comparative Example 9

[0069] This comparative example provides a method for preparing a Tripterygium wilfordii extract, which differs from Example 1 in that only reflux extraction is performed twice, and other conditions are the same.

[0070] Effect Example 1

[0071] This effect example uses the extracts of Tripterygium wilfordii prepared in Examples 1-3 and Comparative Examples 1-9 as samples to explore the content of flavonoids and polyphenol active ingredients therein. The specific method is as follows:

[0072] Table 1

[0073]

[0074] From the results in Table 1, it can be seen that the powder of trifoliate with smaller particles has a larger specific surface area, which can be more effectively dissolved and extracted in the solvent, thereby increasing the content of flavonoid polyphenols. The appropriate particle size is easier to maintain stability during the extraction process, while too fine particles may be more easily destroyed by the solvent, resulting in degradation or oxidation of some flavonoid polyphenols, thereby affecting the final content. Therefore, 40-60 mesh is the most appropriate; the continuous high temperature and concentration gradient of heating and reflux are more conducive to the reaction, which can promote the release and dissolution of flavonoids and polyphenols, while the ultrasonic extraction time is too short to achieve the effect of full extraction, so the heating and reflux extraction method is the best; the volume fraction of ethanol is too low and the polarity is strong, which may not effectively dissolve flavonoids and polyphenols, and at the same time cannot effectively destroy the plant cell wall, making it difficult for the flavonoids and polyphenols inside the cell to be released into the solvent. If the volume fraction of ethanol is too high, the amount of alcohol-soluble and fat-soluble substances dissolved will increase, resulting in a decrease in the dissolution rate of flavonoid compounds. Therefore, the best ethanol volume fraction is 60-70%; if the temperature is too low, the penetration and dissolution effect of the solvent ethanol on the trifoliate cells will be weakened, the extraction rate will slow down, and the extraction of flavonoid polyphenol active substances will be insufficient. If the temperature is too high, the amount of impurities dissolved will increase, hindering the dissolution of flavonoid polyphenols. Therefore, the best heating reflux temperature is 75℃-85℃; if the number of extractions is too small or the extraction time is too short, the effective active ingredients such as flavonoid polyphenols in trifoliate will be incompletely extracted. If the number of extractions is too large or the extraction time is too long, the number of alcohol-soluble substances will increase, and some flavonoid polyphenols may be oxidized, resulting in a decrease in the extraction rate. Therefore, it is best to select three extractions and the third extraction time as 0.5-1.5h.

[0075] The present invention combines the above specific process conditions to prepare and extract the Trillium extract, so as to maximize the extraction efficiency of flavonoids and polyphenol active ingredients in Trillium, so that when it is applied to cosmetics and other products, it can play a better effect in repairing sun damage.

[0076] Effect Example 2

[0077] 1. Antioxidant test:

[0078] (1) DPPH free radical scavenging:

[0079] After diluting the extract of Tripterygium wilfordii prepared in Example 1 to different concentrations, refer to the "Cosmetics-Free Radical (DPPH) Scavenging Experiment Method", use 10mL test tubes to set up sample tubes (T), sample background (T0), DPPH tubes (C) and solvent background (C0). For each sample tube (T) of each tested concentration, 3 parallel tubes need to be set up, and 3 parallel tubes need to be set up for DPPH tubes (C). 1mL of Tripterygium wilfordii extract solution of the same concentration is added to each sample tube (T) and sample background (T0). Solvents are supplemented in all test tubes (T, T0, C, C0), water for water-soluble samples, 95% ethanol for oil-soluble samples, and 3mL is added and mixed. 1mL of DPPH ethanol solution is added to the sample tube (T) and DPPH tube (C), and the sample background (T0) and solvent background (C0) are replaced with 95% ethanol, gently shaken, and left to stand at room temperature for 5 minutes. Each reaction solution is transferred into a 1cm cuvette, and the absorbance is measured at 517nm. Calculate the DPPH free radical scavenging rate:

[0080] Clearance (%) = [1-(T-T0) / (C-C0)] × 100%;

[0081] Where:

[0082] T—absorbance value of sample tube, i.e. absorbance value of solution after reaction between sample and DPPH;

[0083] T0—sample background absorbance;

[0084] C—the average of three absorbance values ​​of the DPPH tube, i.e., the absorbance value of the DPPH solution without adding a sample;

[0085] C0—Solvent background absorbance.

[0086] The experimental results are shown in Table 2. The extract of Tripterygium wilfordii has a good scavenging effect on DPPH in the concentration range of 0.5-0.0625 mg / ml, and the higher the concentration, the higher the scavenging rate.

[0087] Table 2

[0088] Concentration (mg / ml) 0.0625 0.125 0.25 0.5 Clearance rate (%) 32.79 48.41 60.76 78.86 SD(%) 0.68 0.92 0.51 0.49

[0089] (2) Hydroxyl free radical scavenging rate:

[0090] After diluting the Tripterygium wilfordii extract prepared in Example 1 with ethanol water to different concentrations, refer to the "Method for Scavenging Phenophenanthroline" and take 1 mL of phenenophenanthroline solution, 1.5 mL of phosphate buffer, and 1 mL of deionized water in a 25 mL volumetric flask in sequence, mix thoroughly and add 1 mL of ferrous sulfate solution. After mixing, add 1 mL of hydrogen peroxide and make up to volume with deionized water; bathe at 37°C for 60 min, measure the absorbance at 510 nm, which is the absorbance A damaged of the damaged bottle; replace the 1 mL of hydrogen peroxide in the damaged bottle with 1 mL of deionized water in the undamaged bottle, and it can be measured that the undamaged bottle A is not damaged at 510 nm. Replace the 1 mL of deionized water in the damaged bottle with 1 mL of Tripterygium wilfordii extract solution in the sample bottle. Calculate the hydroxyl radical scavenging rate:

[0091] CL=(A 样品 -A 损伤 ) / (A 未损 -A 损伤 )×100

[0092] In the formula: CL——hydroxyl radical scavenging rate of the sample, %

[0093] A 样品 ——absorbance value of the sample;

[0094] A 未损 ——Absorbance value of the undamaged group;

[0095] A 损伤 ——Absorbance value of the injury group.

[0096] The experimental results are shown in Table 3. The extract of Tripterygium wilfordii has a good scavenging effect on hydroxyl free radicals in the concentration range of 5-20 mg / ml, and the higher the concentration, the higher the scavenging rate.

[0097] Table 3

[0098]

[0099]

[0100] (3) Lipid peroxidation experiment:

[0101] Ferric thiocyanate method (FTC): Ferric thiocyanate (FTC) colorimetric method is based on the fact that under acidic conditions, lipid oxidation forms peroxides that can 2+ Oxidized to Fe 3+ , then Fe 3+The red complex with thiocyanate ion with maximum absorption in the range of 480-515nm can be formed to measure the absorbance. The extract of Tripterygium wilfordii prepared in Example 1 is added with methanol solution to prepare a 20 mg / mL solution as the sample solution to be tested; 2 mL of the sample solution is taken, 2 mL of linoleic acid solution and 4 mL of PBS buffer are added, and the blank is measured with methanol solution; the control solution and the sample solution are placed in a 40°C constant temperature incubator for 24h, 48h, 72h, 96h, and 120h before being measured.

[0102] Determination method: Take 0.1 mL of sample solution, add 4.7 mL of 75% ethanol solution, 0.1 mL of 30% ferric thiocyanate solution, and 0.1 mL of ferrous chloride solution, mix well; let stand for 3 minutes, and measure the absorbance of the mixture at a wavelength of 500 nm. Calculate the linoleic acid peroxidation inhibition rate:

[0103] Linoleic acid peroxidation inhibition rate = [100-(OD 样品 / OD 对照 )]×100%

[0104] The experimental results are shown in Table 4. The extract of Tripterygium wilfordii has a good inhibitory effect on linoleic acid peroxidation at a concentration of 10 mg / ml.

[0105] Table 4 Linoleic acid peroxidation inhibition rate of 10 mg / ml Tripterygium wilfordii extract

[0106] Time (h) 24 48 72 96 120 Clearance rate (%) 26.02 36.19 43.06 50.95 57.37

[0107] (4) ROS scavenging experiment:

[0108] 24 48-hour-old zebrafish embryos were exposed to the 0.5% solution of Trigonella extract prepared in Example 1, and a blank control group and a positive control group (0.5% glutathione) were set up at the same time. After 24 hours of exposure, the fish embryos were stained with H2DCFDA, and the ROS signal intensity was measured by fluorescence photography and statistical analysis was performed. Calculation of reactive oxygen species (ROS) clearance rate:

[0109] Clearance rate = (BS) / B × 100%;

[0110] Where:

[0111] S—the average value of the “average signal intensity” of ROS in the fish embryos of the test substance treatment group;

[0112] B—The average value of “average signal intensity” of ROS in fish embryos of the blank control group;

[0113] The results are as follows Figure 1As shown, under the same test conditions, the ROS inhibition rate of glutathione is 15%, while the ROS scavenging rate of the Tripterygium wilfordii extract prepared by the present invention reaches 24%, which has good antioxidant effect.

[0114] (5) AGEs clearance experiment:

[0115] The extract of Trigonella ternata prepared in Example 1 was prepared into a solution with a concentration of 1% with deionized water for testing. A mixed solution containing BSA and glucose was prepared using phosphate buffered saline (PBS), and filtered as a 2× glycosylation reaction solution. Prepare each group of reaction systems in test tubes A (1 ml 2× glycosylation reaction solution, 1 ml sample / reference solution), B (1 ml sample / reference solution, 1 ml PBS), C (1 ml 2× glycosylation reaction solution, 1 ml sample / reference solution) and D (1 ml sample / reference solution, 1 ml PBS). After mixing evenly, place in a digital constant temperature water bath and incubate for 4 days. Use phosphate buffered saline (PBS) instead of the sample as a negative control, aminoguanidine hydrochloride solution as a positive control, and use phosphate buffered saline (PBS) instead of the glycosylation reaction solution as a control system. After the reaction, the incubated solution was cooled to room temperature for measurement, and 200 μL of the reaction solution was added to a 96-well plate in sequence. The fluorescence intensity was detected using a multifunctional microplate reader at an excitation wavelength of 370 nm and an emission wavelength of 440 nm to calculate the AGEs inhibition rate.

[0116] AGEs inhibition rate (%) = [(CD) Mean -(AB)] / (CD) Mean ×100%;

[0117] Where:

[0118] A: fluorescence intensity of the glycosylation system after adding the test substance;

[0119] B: Fluorescence intensity of PBS solution with added test substance;

[0120] C: fluorescence intensity of the glycosylation system without adding the test substance;

[0121] D: Fluorescence intensity of PBS solution without adding the test substance.

[0122] The experimental results are shown in Table 5. The AGEs inhibition rate of the Tripterygium wilfordii extract at a concentration of 1% was 19.10%, which was significantly higher than the AGEs inhibition rate of the negative control (P<0.05), indicating that the Tripterygium wilfordii extract has anti-glycation effect.

[0123] Table 5 AGEs inhibition results of 1% Tripterygium wilfordii extract

[0124] Group AGEs inhibition rate (average value) Standard Deviation Significant difference Sample set 19.10% 3.52% P<0.05 Positive control group 91.04% 2.74% P<0.05 Negative control group 0.00% 11.80% /

[0125] Whether or not oxidative stress can be effectively inhibited is one of the important indicators for evaluating the therapeutic effect of a product on sun damage. Therefore, in summary, the Tripterygium wilfordii extract prepared by the present invention can effectively scavenge free radicals, inhibit lipid peroxidation and the expression of ROS, reduce the formation of AGEs, and reduce oxidative stress reactions, thereby reducing skin sun damage caused by ultraviolet rays.

[0126] 2. Test for inhibiting inflammatory response:

[0127] Keratinocytes were irradiated with UVB, and the gene expressions of NF-κB and HMGB1 and the content of TNF-α were determined.

[0128] (1) Cytotoxicity test:

[0129] The MTT method was used to detect cytotoxicity and determine the administration concentration of the Trigonella lobata extract on keratinocytes. After the cells were revived, when the plating rate reached about 60%, the cells were inoculated into 96-well plates and incubated overnight in a CO2 incubator (37°C, 5% CO2). The experiment set up a zeroing group, a solvent control group, a positive control group and a sample group. The Trigonella lobata extract in the sample group was set at 8 concentrations (0.5%, 0.25%, 0.125%, 0.0625%, 0.0313%, 0.0156%, 0.0078%, 0.0039%), and 3 replicate wells were set at each concentration. The drug was administered when the cell plating rate in the 96-well plate reached 50%-60%. 200 μL of culture medium was added to each well of the solvent control group; 200 μL of culture medium containing 10% DMSO was added to each well of the positive control group; 200 μL of culture medium containing the corresponding concentration of sample was added to each well of the sample group; the zero adjustment group had no cell inoculation and only 200 μL of cell culture medium was added. After the administration was completed, the 96-well plate was placed in a CO2 incubator (37°C, 5% CO2) and cultured for 24 hours. After the cells were incubated for 24 hours, the supernatant was discarded, and MTT working solution (0.5 mg / mL) was added. Incubated at 37°C in the dark for 4 hours. After the incubation was completed, the supernatant was discarded, 150 μL DMSO was added to each well, and the OD value was read at 490 nm. Calculate according to the formula:

[0130] Relative cell viability (%) = (OD of sample well - OD of zero-adjustment well) / (OD of solvent control well - OD of zero-adjustment well) × 100%;

[0131] The test results are shown in Table 6. The extract of Tripterygium wilfordii showed no obvious cytotoxicity within the concentration range of 0.0156% based on keratinocytes.

[0132] Table 6 Results of MTT test on keratinocytes of Tripterygium wilfordii extract

[0133]

[0134] (2) Inhibition of NF-κB, HMGB1, and TNF-α expression detection:

[0135] After the cells were revived, when the plating rate reached about 60%, the cells were inoculated into 6-well plates and incubated overnight in a CO2 incubator (37°C, 5% CO2). When the cell plating rate in the 6-well plate reached 30%-50%, the drugs were divided into groups and administered, with 3 replicates in each group. 2 mL of culture medium was added to each well of the blank control group and the negative control group, 2 mL of culture medium containing dexamethasone was added to each well of the PC group, and 2 mL of culture medium containing 0.02% Trigonella ternata extract was added to each well of the sample group. Except for the blank control group, the remaining groups were irradiated with UVB at a dose of 300 mJ / cm 2 After irradiation, the cells were placed in a CO2 incubator (37°C, 5% CO2) and cultured for 24 hours. After incubation, the cell culture supernatant was collected and ELISA was performed to detect TNF-α according to the instructions of the ELISA kit. The cells were washed twice with PBS, 1 mL of RNAisoPlus was added to each well, and the cells were lysed by blowing and then collected. RNA was extracted and reverse transcribed to cDNA, and then fluorescence quantitative PCR was performed to detect the expression results of HMGB1 and NF-κB genes. -△△CT Method to calculate the results.

[0136] Inhibition rate (%) = (negative control group - sample group) / negative control group × 100%;

[0137] The results are shown in Tables 7-9. 0.02% of the extract of Tripterygium wilfordii effectively inhibited the gene expressions of NF-κB and HMGB1 and the content of TNF-α, with inhibition rates of 59.31%, 33.57% and 20.00%, respectively.

[0138] When the t-test method was used for statistical analysis, compared with the BC group, the significance was indicated by #, P-value < 0.05 was indicated by #, and P-value < 0.01 was indicated by ##; compared with the NC group, the significance was indicated by *, P-value < 0.05 was indicated by *, and P-value < 0.01 was indicated by **.

[0139] Table 7 Summary of NF-κB gene detection results

[0140]

[0141] Table 8 Summary of HMGB1 gene detection results

[0142]

[0143]

[0144] Table 9 Summary of TNF-α content test results

[0145]

[0146] The inflammatory signaling pathway protein NF-κB is a nuclear transcription factor. When activated by phosphorylation, it will enter the cell nucleus and bind to the promoter region of downstream target genes to initiate the transcription of downstream target genes, among which downstream target genes are mainly factors related to inflammatory response. Therefore, inhibiting NF-κB can inhibit inflammatory response. The function of HMGB1 is to recruit inflammatory cells and mediate signals between macrophages, dendritic cells and natural killer cells. Extracellular HMGB1 can activate endothelial cells, promote angiogenesis, enhance hematopoietic stem cell migration, and induce local or systemic inflammation. TNF-α is a proinflammatory factor and the earliest and most important inflammatory mediator in the inflammatory response. It can activate neutrophils and lymphocytes, increase the permeability of vascular endothelial cells, regulate the metabolic activity of other tissues, and promote the synthesis and release of other cytokines, inducing inflammatory response.

[0147] In summary, based on keratinocytes, compared with the control group, the extract of Tripterygium wilfordii can significantly downregulate the expression of NF-κB and HMGB1 genes induced by ultraviolet rays, inhibit the secretion of inflammatory factors (TNF-α), reduce the inflammatory response, and thus reduce skin damage caused by ultraviolet rays.

[0148] 3. Pigmentation inhibition test:

[0149] (1) UVB irradiation of keratinocytes to measure α-MSH content and β-catenin gene expression

[0150] Same as the inflammatory response inhibition test, after the cytotoxicity MTT test, the extract of Trigonella lanceolata with a concentration of 0.02% was finally selected for subsequent experiments. After the cells were revived, when the plating rate reached about 60%, the cells were inoculated into 6-well plates and incubated overnight in a CO2 incubator (37°C, 5% CO2). When the cell plating rate in the 6-well plate reached 30%-50%, the drugs were divided into groups for administration, with 3 replicate wells in each group. 2mL of culture medium was added to each well of the blank control group and the negative control group, 2mL of culture medium containing VE was added to each well of the PC group, and 2mL of culture medium containing 0.02% Trigonella lanceolata extract was added to each well of the sample group. Except for the blank control group, the remaining groups were irradiated with UVB, and the irradiation dose was 300mJ / cm 2After irradiation, the cells were placed in a CO2 incubator (37°C, 5% CO2) and cultured for 24 hours. After incubation, the cell culture supernatant was collected and α-MSH was detected by ELISA according to the instructions of the ELISA kit. The cells were washed twice with PBS, 1 mL of RNAisoPlus was added to each well, and the cells were lysed by blowing and then collected. RNA was extracted and reverse transcribed to cDNA, and the expression results of β-catenin gene were detected by fluorescence quantitative PCR. -△△CT Method to calculate the results.

[0151] Inhibition rate (%) = (negative control group - sample group) / negative control group × 100%;

[0152] The results are shown in Tables 10-11. 0.02% of Tripterygium wilfordii extract effectively inhibited the content of α-MSH and the gene expression of β-catenin, with inhibition rates of 53.34% and 54.23%, respectively.

[0153] When the t-test method was used for statistical analysis, compared with the BC group, the significance was indicated by #, P-value < 0.05 was indicated by #, and P-value < 0.01 was indicated by ##; compared with the NC group, the significance was indicated by *, P-value < 0.05 was indicated by *, and P-value < 0.01 was indicated by **.

[0154] Table 10 Summary of α-MSH content test results

[0155]

[0156] Table 11 Summary of β-catenin gene test results

[0157]

[0158] α-MSH is mainly produced by melanocytes and keratinocytes through autocrine and paracrine mechanisms, and keratinocytes are the main source of α-MSH. α-MSH can quickly increase the activity of tyrosinase, stimulate the increase of melanocyte dendrites, and promote the transfer of melanosomes to surrounding keratinocytes. β-catenin accumulates in the cytoplasm and then translocates to the nucleus, which is considered to be a sign of the activation of the Wnt signaling pathway. The secretory glycoprotein Wnt plays an important role in the development of melanocytes. In the Wnt / β-catenin signaling pathway, after the Wnt ligand binds to the membrane receptor G protein-coupled receptor Frizzled, it blocks the activity of glycogen synthase kinase to prevent β-catenin from being phosphorylated and degraded. The accumulated β-catenin is transported to the nucleus through Rac1 and other factors, and binds to the lymphoid enhancer factor-1 / T cell factor (LEF-TCF) transcription complex, so that the increase in the concentration of β-catenin in the nucleus promotes the expression of MITF, thereby promoting the synthesis of intracellular melanin.

[0159] In summary, 0.02% of Tripterygium wilfordii extract, based on keratinocytes, significantly downregulated the content of α-melanocyte stimulating hormone (α-MSH) and the gene expression of β-catenin compared with the control group, and effectively inhibited the signal transduction in the process of ultraviolet-induced melanin production.

[0160] (2) Inhibit melanin production:

[0161] Similarly, the MTT method was used to determine the cytotoxicity of the Trigonella lobata extract in melanocytes. Finally, the Trigonella lobata extract with a concentration of 0.03% was selected for the melanin inhibition test. The cytotoxicity results are shown in Table 12 below:

[0162] Table 12 Results of MTT test on B16 cells of Tripterygium wilfordii extract

[0163]

[0164] The effect of Trillium extract on cell melanin content was determined by referring to the "In vitro Cosmetic Test B16 Cell Melanin Synthesis Inhibition Experiment" (T / SHRH027-2019): the cell density was adjusted to 2.5×10 3 / mL, and then spread the cell suspension in a 6-well plate, 2mL per well. Note: Each test requires a negative control group, a test sample group and a positive control group, and three replicates are set up for each group. After the 6-well plate is placed in a 37°C, 5% CO2 incubator for 20-24 hours, the cell culture medium is replaced with a culture medium containing the test sample, 2mL per well, and culture is continued for 48 hours. 48 hours after the first change of medium, repeat the steps, replace the cell culture medium, adjust to add 3mL of culture medium containing the corresponding sample to each well, and continue to culture in a 37°C, 5% CO2 incubator. 72 hours after the second change of medium, repeat the steps, replace the cell culture medium, add 3mL of culture medium containing the sample to each well, and continue to culture in a 37°C, 5% CO2 incubator. 48-72 hours after the third change of medium (cell fusion rate reaches more than 90%), measure the cell melanin content. Wash the cells twice with 1×PBS, remove the PBS, add 200μL of 0.25% trypsin to each well to digest the cells, and place them in a CO2 incubator for digestion for 5 minutes. Add 2mL of PBS twice to blow the cells, collect the cells into a centrifuge tube, and centrifuge at 4000rpm for 5 minutes. Try to suck out the residual PBS in the centrifuge tube, add 200μL of melanin extract to each tube, shake evenly, and heat in an 80℃ water bath for 1 hour. After cooling, centrifuge the droplets on the tube wall moderately, blow evenly, aspirate 150μL of solution in each centrifuge tube, transfer to a 96-well plate, and use an enzyme reader to detect the absorbance of each well at 405nm. Calculate the melanin synthesis inhibition rate:

[0165] Inhibition rate (%) = (CT) / (C-C0) × 100%;

[0166] Where:

[0167] T—absorbance of the test sample well;

[0168] C—average of three absorbance values ​​of the negative control group;

[0169] C0—Background absorbance of melanin extract.

[0170] The results are shown in Table 13. The melanin inhibition rate of 0.03% Tripterygium wilfordii extract was 33.08%. The production of melanin by melanocytes in the skin is the main cause of skin darkening and the formation of spots, indicating that Tripterygium wilfordii extract can effectively inhibit the production of melanin.

[0171] Table 13 The results of the inhibition of melanin content in B16 cells by Tripterygium wilfordii extract

[0172]

[0173] (3) Co-culture of keratinocytes and melanocytes to determine the transport of melanosomes

[0174] Similarly, the MTT method was used to determine the cytotoxicity of the extract of Trigonella lobata in the co-culture system of keratinocytes and melanocytes. Finally, 0.12% and 0.06% concentrations of Trigonella lobata extract were selected for the melanosome transport test experiment. The cytotoxicity results are shown in Table 14:

[0175] Table 14 MTT test results of co-culture of keratinocytes and melanocytes with Tripterygium wilfordii extract

[0176]

[0177] After the cells in the logarithmic growth phase were digested and centrifuged with 0.25% trypsin, a cell suspension of appropriate density was prepared with complete culture medium, and HaCaT cells and A375 cells were prepared into a cell suspension at a ratio of 10:1; a cell slide was placed in each well of the 12-well plate, and 1 mL was inoculated into each well of the 12-well culture plate according to the experimental requirements and co-cultured in a 37°C, 5% CO2 incubator for 24±2h. The original culture medium in the 12-well plate was removed, and the samples were added according to the experimental groups. The culture medium containing 0.12% and 0.06% concentrations of Trigonella lanceolata extract and α-MSH inducer were added to each well of the experimental group, and the same concentration of α-MSH inducer was added to the model group. The blank control group only added culture medium, 1 mL per well, and continued to culture in a 37°C, 5% CO2 incubator for 24±2h. After the incubation, the original culture medium was discarded, PBS was washed 2-3 times, and each well was fixed with fixative for 20 minutes, and then blocked. Add primary antibody and incubate at 2-8℃ overnight or incubate at 37℃ for 1.5h; wash 2-3 times with PBS, add secondary antibody and incubate at room temperature for 1h or incubate at 37℃ for 40min, and finally stain the nucleus with Hoechst33342 live cell staining solution for 10min. Note: The whole process from incubation of secondary antibody should be operated in a dark room to avoid fluorescence quenching. Transfer the cell slide to a dark room and take pictures with a fluorescence microscope. The collected pictures are analyzed for image fluorescence intensity using ImageJ software.

[0178] Calculate the absolute fluorescence intensity of melanosomes:

[0179] Melanosome absolute fluorescence intensity = melanosome average fluorescence intensity / cell nucleus average fluorescence intensity Melanosome relative content calculation formula:

[0180] Melanosome relative content (%) = T / C × 100%;

[0181] Where:

[0182] T—absolute fluorescence intensity value of melanosomes in the tested sample;

[0183] C—Average absolute fluorescence intensity of melanosomes in the model group.

[0184] The calculation formula of melanosome transport inhibition rate is:

[0185] Inhibition rate (%) = (1-T / C) × 100%;

[0186] Where:

[0187] T—average value of relative content of melanosomes in the tested samples;

[0188] C—The average value of the relative content of melanosomes in the model group.

[0189] The results are as follows Figure 2-3 As shown: The results of fluorescence microscopy observation (red fluorescence is melanosomes, the brighter the fluorescence, the more melanosomes there are) showed that the relative content of melanosomes in the co-culture system of HaCaT cells and A375 cells was 7.45% and 43.84% respectively when the extract of Tripterygium wilfordii was used at a concentration of 0.12% and 0.06%, which was significantly reduced compared with the model group (100%) (P<0.05). The inhibition rates of melanosome transport were 92.55% and 56.16% respectively.

[0190] When exposed to ultraviolet rays, the melanin precursors in the cells are oxidized, and melanin is synthesized and redistributed. Keratinocytes co-transport and accumulate, which eventually causes changes in skin pigmentation. Melanin is produced in special dendritic cells, namely melanocytes. Melanin is synthesized through a cascade reaction triggered by tyrosinase, in which tyrosine is converted into melanin. During the continuous deposition of melanin in melanosomes, it is also transported to the dendritic ends of melanocytes. Melanosomes will be transferred to keratinocytes through possible mechanisms such as endocytosis, exocytosis, and membrane fusion, resulting in a melanization of the skin.

[0191] In summary, the extract of Trillium can not only effectively inhibit the production of new melanin, but also inhibit the transport of existing melanin, and has a significant improvement effect on skin pigmentation induced by ultraviolet rays.

[0192] Effect Example 3

[0193] The extract of Trigonella ovata prepared in Example 1 was prepared into an emulsion dosage form for subsequent clinical human testing, wherein the content of the Trigonella ovata extract was 2%.

[0194] 1. The formula and process are as follows:

[0195] Phase A: 3.0wt% glycerol, 0.35wt% polyacrylate cross-linked polymer-6, 0.35wt% sodium metabisulfite, 0.06wt% xanthan gum, 0.06wt% sodium hyaluronate, 0.50wt% p-hydroxyacetophenone, 0.60wt% 1,2-hexanediol, 4.00wt% propylene glycol;

[0196] Phase B: squalane 2.00wt%, caprylic / capric glycerin 3.00wt%, isopropyl myristate 4.00wt%, tocopherol 0.15wt%, MONTANOV TM L 0.60wt%, stearic acid 0.30wt%, cetearyl alcohol 2.00wt%, 1000 1.50wt%, Span 60 0.40wt%;

[0197] Phase C: 2.00 wt% of Tripterygium wilfordii extract, the rest is deionized water.

[0198] The preparation method of the emulsion comprises the following steps:

[0199] (1) Accurately weigh phase A, heat in a water bath at 80°C, and quickly homogenize for 5 min until uniform. Set aside;

[0200] (2) Accurately weigh phase B, heat and dissolve phase B, add phase B to phase A, homogenize for 5 minutes, and stir;

[0201] (3) When the temperature of the material body drops below 50° C., phase C is added and stirred evenly, and the temperature is lowered to room temperature. The material is discharged to obtain the emulsion containing the Trigonella ternata extract for subsequent human trials.

[0202] 2. Safety test:

[0203] (1) Subjects: 30 outdoor workers (20 females and 10 males) were screened. They had facial redness, damaged skin barrier or uneven skin color, obvious pigmentation, etc. They were aged between 25 and 65 years old. All subjects had no history of skin or systemic diseases, no abnormalities in the test area, and did not apply any drugs or cosmetics unrelated to the experiment during the test.

[0204] (2) Test environment: The test site is kept at a constant temperature and humidity, with an ambient temperature of 20°C to 22°C and a relative humidity of 40% to 60%. The subject should keep the body in a stable state before the test. After washing the subject's face with clean water at about 35°C, the subject should sit quietly in the test environment for 30 minutes before starting the test.

[0205] (3) Test method: The emulsion containing Trigonella oleracea extract prepared above was subjected to a patch test. Qualified patch test equipment was selected and a closed patch test method was used. About 0.020-0.025 ml of the test substance was placed in the patch tester. The patch was then applied to the curved side of the subject's forearm with medical tape. The palm of the hand was used to gently press the patch to evenly adhere to the skin. After 24 hours, the test substance patch was removed and the skin reaction was observed at 0.5, 24, and 48 hours after the removal of the test substance patch.

[0206] The results of human skin patch tests showed that there were no adverse skin reactions among 30 people, and the samples were safe and non-irritating.

[0207] 3. Human testing:

[0208] The 30 subjects selected above were subjected to human trials to explore the effect of the prepared lotion containing Trillium extract on improving skin damage after sun exposure.

[0209] How to use the sample: Use twice a day, once in the morning and once in the evening after cleansing, about 1g of sample each time, for 56 consecutive days.

[0210] The cheeks of volunteers were selected as the test site, and VISIA tests were performed before using the test product and on the 28th and 56th days of continuous use of the product. The comparison of pigmentation, UV pigmentation, brown pigmentation and red areas of a representative subject before use and after 56 days of use is shown below: Figure 4-7 As shown, the spot feature count decreased by 3.3%, the UV spot feature count decreased by 2.7%, the brown spot feature count decreased by 16.6%, and the red area feature count decreased by 22.9%. This shows that the lotion containing Tripterygium wilfordii extract can effectively reduce skin inflammation and tanning reactions caused by UV rays, reduce redness and pigmentation such as spots, UV spots, and brown spots, and has a significant effect in improving skin damage after sun exposure.

[0211] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. Application of Trillium extract in the preparation of external preparations for skin after-sun repair.

2. The use according to claim 1, characterized in that The extract of Tripterygium wilfordii exerts the effect of repairing skin after sun exposure through at least one of the following aspects: a. Inhibit oxidative stress caused by sun damage to skin tissue; b. Inhibit the inflammatory response caused by sun damage to skin tissue; c. Inhibit pigmentation caused by sun damage to skin tissue.

3. The use according to claim 1 or 2, characterized in that: The preparation method of the Tripterygium wilfordii extract comprises the following steps: (1) crushing the three-sided tuber, passing it through a 40-60 mesh sieve, soaking it in an ethanol solution, and then refluxing and extracting it for 1.5-2.5 hours, filtering it to obtain a first extract, and then refluxing and extracting the filter residue with an ethanol solution for 1.5-2.5 hours, filtering it, and obtaining a second extract; (2) Reflux extraction of the filter residue with an ethanol solution for 0.5-1.5 h to obtain a third extract, combine the three extracts, remove the ethanol under reduced pressure, filter and collect the filtrate to obtain the Trillium extract.

4. The use according to claim 3, characterized in that The temperatures of the three reflux extractions were all 75-85°C.

5. The use according to claim 3, characterized in that The volume concentration of the ethanol solution is 60-70%.

6. A cosmetic for skin repair after sun exposure, characterized in that: The cosmetic comprises the Tripterygium wilfordii extract used in any one of claims 1 to 5, and the mass percentage of the Tripterygium wilfordii extract in the cosmetic is 1-60%.

7. The cosmetic according to claim 6, characterized in that The cosmetic dosage form includes at least one of an aqueous solution, an emulsion, and a cream.

8. A skin after-sun repair lotion, characterized in that: The emulsion comprises the Tripterygium wilfordii extract used in any one of claims 1 to 5; the mass percentage of the Tripterygium wilfordii extract in the emulsion is 1-3%.

9. The emulsion according to claim 8, characterized in that The emulsion further comprises 10-15% of moisturizing agent, 5-10% of emulsifier, 0.2-0.7% of antioxidant, 1-3% of thickener, 1-2% of preservative and balance of water.

10. The emulsion according to claim 9, characterized in that The moisturizing agent includes at least one of glycerin, sodium hyaluronate, propylene glycol, squalane, caprylic / capric glyceride, glucose, butylene glycol, 1,2-pentanediol, caprylyl glycol and isopentyl glycol; The emulsifier includes at least one of acrylic acid (ester) / acrylamide copolymer, isopropyl myristate, LC14-22 alcohol, C12-20 alkyl glucoside, stearic acid, cetearyl olivate, sorbitan olivate, Span 80, glyceryl stearate, PEG-100 stearate, steareth-2, steareth-21, ceteareth-12, ceteareth-30, potassium cetyl phosphate, sodium stearoyl glutamate, polysorbate-60 and sorbitan stearate; The antioxidant comprises at least one of sodium pyrosulfite, tocopherol and tocopherol acetate; The thickener comprises at least one of polyacrylate crosspolymer-6, xanthan gum, cetearyl alcohol, carbomer and hydroxyethyl cellulose; The preservative comprises at least one of p-hydroxyacetophenone, 1,2-hexanediol, chlorphenesin, caprylhydroxamic acid, benzyl alcohol, phenoxyethanol, benzoic acid and its salts, and sorbic acid and its salts.

Citation Information

Patent Citations

  • Extraction method of rhizoma sparganii extract and cigarette and essence cream containing rhizoma sparganii extract

    CN106691953A

  • Active probiotic mask and preparation method thereof

    CN110721147A

  • Application of rhizoma sparganii extract in preparation of medicine for treating pulmonary fibrosis

    CN116115715A

  • Traditional Chinese medicine composition for cleaning face and removing acnes, application of traditional Chinese medicine composition and gel containing traditional Chinese medicine composition

    CN116672417A

  • Holistic composition and method for reducing skin pigmentation

    US20050169860A1

Cited By

  • Soothing composition, use and skin care product

    CN120549839B